Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome
- 106 Downloads
Introduction and hypothesis
Multiple publications have demonstrated the efficacy of percutaneous tibial nerve stimulation (PTNS) for overactive bladder syndrome (OAB). However, patient characteristics associated with successful treatment have not been well established.
The aim of this study was to identify prognostic factors for successful PTNS treatment.
This was a retrospective chart review of women who underwent PTNS therapy for OAB between January 2011–Decemeber 2017. Treatment success was defined by subjective improvement according to patient self-report and objective bladder diary parameters including the intervoiding interval, nocturia episodes and urgency urinary incontinence (UUI) episodes per day, before and after PTNS treatment. Baseline symptoms were dichotomized for each symptom based on severity.
One hundred sixty-two women with a mean age of 72.7 ± 11.3 years and BMI of 28.5 ± 7.1 were included in the study. There was a statistically significant improvement in all three OAB symptoms after treatment. Multivariable analysis revealed that a history of depression and anxiety was associated with subjective improvement, whereas decreased subjective improvement was associated with a history of hypertension, prior intravesical onabotulinnumtoxinA injection and sacral neuromodulation. While dichotomizing subjects into two groups defined by < 50% versus ≥ 50% improvement, depression/anxiety, urodynamic volume at first sensation to void and more severe baseline urgency urinary incontinence severity were all significant predictors of subjective improvement.
Among women treated with PTNS for refractory OAB, a history of depression/anxiety and severe baseline urgency urinary incontinence were positive predictors of a successful PTNS outcome.
KeywordsOveractive bladder syndrome Percutaneous tibial nerve stimulation Lower urinary tract symptoms
Compliance with ethical standards
Conflicts of interest
- 1.Haylen BT, Freeman RM, Lee J, Swift SE, Cosson M, Deprest J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related to native tissue female pelvic floor surgery. Int Urogynecol J. 2012;23(5):515–26. https://doi.org/10.1007/s00192-011-1659-x.CrossRefPubMedGoogle Scholar
- 6.Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34(3):224–30.CrossRefGoogle Scholar
- 11.Finazzi Agrò E, Petta F, Bove P, D'Amico A, Germani S, Campagna A, et al. Percutaneous tibial nerve stimulation (PTNS) in the treatment of urge incontinence: a double blind, placebo controlled study. Urodinamica. 2005;15(3):171–2.Google Scholar
- 12.Peters K, MacDiarmid S, Wooldridge L, Leong F, Shobeiri S, Rovner E, et al. Neurourol Urodyn. 2009;7:881–2.Google Scholar